{
  "id": "61fbc613c9dfcb9c09000010",
  "type": "list",
  "question": "What drugs are included in the Avandamet pill?",
  "ideal_answer": "The combination of metformin and rosiglitazone in a single pill (Avandamet), was approved by the FDA in October 2002 for the treatment of diabetes.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
    "http://www.ncbi.nlm.nih.gov/pubmed/17026489",
    "http://www.ncbi.nlm.nih.gov/pubmed/20840734",
    "http://www.ncbi.nlm.nih.gov/pubmed/19419339",
    "http://www.ncbi.nlm.nih.gov/pubmed/25963345",
    "http://www.ncbi.nlm.nih.gov/pubmed/21682834",
    "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
    "http://www.ncbi.nlm.nih.gov/pubmed/16240868",
    "http://www.ncbi.nlm.nih.gov/pubmed/19105408"
  ],
  "snippets": [
    {
      "text": "Our method detected the combination of Metformin and Rosiglitazone, which is actually Avandamet, a drug that has been successfully used to treat Type 2 Diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20840734",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: The long-term cost-effectiveness of using pioglitazone plus metformin (Actoplusmet dagger) compared with rosiglitazone plus metformin (Avandamet double dagger) in treating type 2 diabetes (T2DM) was assessed from a US third-party payer perspective.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19419339",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The combination of metformin and rosiglitazone in a single pill (Avandamet), was approved by the FDA in October 2002 for the treatment of diabetes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The combination of metformin and rosiglitazone in a single pill (Avandamet), was approved by the FDA in October 2002 for the treatment of diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIM: This study assessed the efficacy and safety of rosiglitazone and metformin (RSG/MET) fixed-dose combination (AVANDAMET) as initial therapy in patients with uncontrolled type 2 diabetes compared with monotherapy with either RSG or MET after 32 weeks of treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17026489",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "metformin and rosiglitazone in a single pill (Avandamet), was approved by the FDA in October 2002 for the treatment of diabetes. As insulin resistan",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "single-tablet combination of metformin and rosiglitazone, Avandamet, has become available. Avandamet is ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: At present, China has listed the compound tablet containing a fixed dose of rosiglitazone and metformin, Avandamet, which may improve patient c",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25963345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The combination of metformin and rosiglitazone in a single pill (Avandamet), was approved by the FDA in October 2002 for the treatment of diabetes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17563269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: At present, China has listed the compound tablet containing a fixed dose of rosiglitazone and metformin, Avandamet, which may improve patient complianc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25963345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIM: To study effects of avandia and its combination with metformine (avandamet) on secretion of fat tissue hormone",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19105408",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na\u00efve type 2 diabetes mellitus patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21682834",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, a single-tablet combination of metformin and rosiglitazone, Avandamet, has become available",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In summary, Avandamet is a single-tablet metformin-rosiglitazone combination that doubly targets insulin resistance as therapy for hyperglycaemia and vascular risk in type 2 diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: At present, China has listed the compound tablet containing a fixed dose of rosiglitazone and metformin, Avandamet, which may improve patient",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25963345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, a single-tablet combination of metformin and rosiglitazone, Avandamet, has become available.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIM: This study assessed the efficacy and safety of rosiglitazone and metformin (RSG/MET) fixed-dose combination (AVANDAMET) as initial therapy in patients with uncontrolled type 2 diabetes compared with monotherapy with either RSG or MET after 32 weeks of treatment.METHODS: A total of 468 drug-naive patients with uncontrolled type 2 diabetes were recruited for this multicentre, double-blind trial if their glycated haemoglobin (A1c) was greater than 7.5%, but less than or equal to 11%, and their fasting plasma glucose (FPG) was less than or equal",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17026489",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Avandamet is suitable for type 2 diabetic patients who are inadequately controlled by monotherapy with metformin or rosiglitazone.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of Avandamet requires attention to the precautions for both metformin and rosiglitazone, especially renal, cardiac and hepatic competence.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15529521",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "eat Type 2 Diabetes. Our method detected the combination of Metformin and Rosiglitazone, which is actually Avandamet, a drug that has been successfully used to treat Type 2 Diabetes.CONCLUSIONS: The results on real biological data demonstrate the effectiveness and efficiency of the proposed method, which can not only detect effective cocktail combination of drugs in an accurate manner but also significantly reduce expensive and te",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20840734",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Finally there are 'fixed combinations of two molecules so as glibenclamide + metformin (Glucovance) or rosiglitazone + metformin (Avandamet).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16240868",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "metformin, rosiglitazone"
}